Meyer WH - Search Results

1

Topoisomerase I interactive drugs in children with cancer.

Stewart CF, Zamboni WC, Crom WR, Gajjar A, Heideman RL, Furman WL, Meyer WH, Houghton PJ, Pratt CB. Stewart CF, et al. Among authors: meyer wh. Invest New Drugs. 1996;14(1):37-47. doi: 10.1007/BF00173681. Invest New Drugs. 1996. PMID: 8880392 Review.

2

Phase I study of 4'-deoxydoxorubicin (esorubicin) in children with malignant solid tumors.

Pratt CB, Douglass EC, Meyer WH, Hayes FA, Horowitz ME, Thompson EI, Avery L. Pratt CB, et al. Among authors: meyer wh. Invest New Drugs. 1989 Jul;7(2-3):209-11. doi: 10.1007/BF00170859. Invest New Drugs. 1989. PMID: 2793374

3

A phase I study of sulofenur in refractory pediatric malignant solid tumors.

Pratt CB, Bowman LC, Marina N, Pappo A, Avery L, Luo X, Meyer WH. Pratt CB, et al. Among authors: meyer wh. Invest New Drugs. 1995;13(1):63-6. doi: 10.1007/BF02614222. Invest New Drugs. 1995. PMID: 7499110 Clinical Trial.

4

Interpatient variability in bioavailability of the intravenous formulation of topotecan given orally to children with recurrent solid tumors.

Zamboni WC, Bowman LC, Tan M, Santana VM, Houghton PJ, Meyer WH, Pratt CB, Heideman RL, Gajjar AJ, Pappo AS, Stewart CF. Zamboni WC, et al. Among authors: meyer wh. Cancer Chemother Pharmacol. 1999;43(6):454-60. doi: 10.1007/s002800050923. Cancer Chemother Pharmacol. 1999. PMID: 10321504

5

Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children.

Furman WL, Stewart CF, Poquette CA, Pratt CB, Santana VM, Zamboni WC, Bowman LC, Ma MK, Hoffer FA, Meyer WH, Pappo AS, Walter AW, Houghton PJ. Furman WL, et al. Among authors: meyer wh. J Clin Oncol. 1999 Jun;17(6):1815-24. doi: 10.1200/JCO.1999.17.6.1815. J Clin Oncol. 1999. PMID: 10561220 Clinical Trial.

6

Phase I study of combination topotecan and carboplatin in pediatric solid tumors.

Athale UH, Stewart C, Kuttesch JF, Moghrabi A, Meyer W, Pratt C, Gajjar A, Heideman RL. Athale UH, et al. J Clin Oncol. 2002 Jan 1;20(1):88-95. doi: 10.1200/JCO.2002.20.1.88. J Clin Oncol. 2002. PMID: 11773158 Clinical Trial.

7

Use of GM-CSF in children after high-dose chemotherapy.

Furman WL, Fairclough D, Cain AM, Arnold BA, Pratt CB, Meyer WH, Crist WM. Furman WL, et al. Among authors: meyer wh. Med Pediatr Oncol Suppl. 1992;2:26-30. doi: 10.1002/mpo.2950200707. Med Pediatr Oncol Suppl. 1992. PMID: 1306884

8

Phase I study of flavone acetic acid (NSC 347512, LM975) in patients with pediatric malignant solid tumors.

Pratt CB, Relling MV, Meyer WH, Douglass EC, Kellie SJ, Avery L. Pratt CB, et al. Among authors: meyer wh. Am J Clin Oncol. 1991 Dec;14(6):483-6. doi: 10.1097/00000421-199112000-00005. Am J Clin Oncol. 1991. PMID: 1957836 Clinical Trial.

9

Use of investigational drugs as initial therapy for childhood solid tumors.

Meyer WH, Houghton PJ, Horowitz ME, Etcubanas E, Pratt CB, Hayes FA, Thompson EI, Green AA, Houghton JA, Sandlund JT, et al. Meyer WH, et al. Haematol Blood Transfus. 1989;32:141-8. doi: 10.1007/978-3-642-74621-5_25. Haematol Blood Transfus. 1989. PMID: 2625241 No abstract available.

10

Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumors.

Marina NM, Rodman JH, Murry DJ, Shema SJ, Bowman LC, Jones DP, Furman W, Meyer WH, Pratt CB. Marina NM, et al. Among authors: meyer wh. J Natl Cancer Inst. 1994 Apr 6;86(7):544-8. doi: 10.1093/jnci/86.7.544. J Natl Cancer Inst. 1994. PMID: 8133538 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters